|
|
|
Insider
Information: |
Spiegelman Daniel K |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
155,668 |
|
Indirect Shares
|
6,673 |
|
|
Direct
Value |
$5,014,809 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
162,341 |
|
|
Total
Value |
$5,014,809 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
CV Therapeutics Inc |
CVTX |
SVP, CFO |
2009-04-09 |
67,489 |
2009-04-09 |
6,673 |
Premium* |
|
Cascadian Therapeutics, Inc |
CASC |
Director |
2018-03-09 |
0 |
2009-12-04 |
0 |
Premium* |
|
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Financial O... |
2019-04-30 |
47,686 |
2012-05-29 |
0 |
Premium* |
|
Relypsa Inc |
RLYP |
Director |
2016-09-01 |
0 |
2015-06-04 |
0 |
Premium* |
|
Myriad Genetics Inc |
MYGN |
Director |
2023-06-02 |
40,493 |
2020-05-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
180 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CASC |
Cascadian Therapeutics, I... |
Director |
|
2009-12-04 |
4 |
A |
$0.00 |
$0 |
D/D |
6,185 |
6,185 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2010-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
8,086 |
14,271 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2011-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
4,538 |
18,809 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2011-06-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,076 |
20,885 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2011-12-04 |
4 |
D |
$6.86 |
$10,606 |
D/D |
(1,546) |
19,339 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2012-06-07 |
4 |
A |
$3.67 |
$29,999 |
D/D |
8,174 |
25,492 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2013-02-20 |
4 |
S |
$1.96 |
$25,054 |
D/D |
(12,780) |
24,047 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2013-06-09 |
4 |
D |
$1.86 |
$2,111 |
D/D |
(1,135) |
24,357 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2013-07-10 |
4 |
S |
$1.72 |
$5,854 |
D/D |
(3,403) |
20,644 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2014-03-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,352 |
43,709 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2014-03-11 |
4 |
D |
$3.65 |
$17,659 |
D/D |
(4,838) |
38,871 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2014-06-07 |
4 |
D |
$3.06 |
$6,255 |
D/D |
(2,044) |
36,827 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2015-03-25 |
4 |
B |
$1.63 |
$16,271 |
D/D |
10,000 |
30,644 |
2.39 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2015-03-26 |
4 |
B |
$1.59 |
$15,856 |
D/D |
10,000 |
40,644 |
2.39 |
- |
|
RLYP |
Relypsa Inc |
Director |
|
2015-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
2,250 |
2,250 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2015-06-13 |
4 |
D |
$3.88 |
$15,563 |
D/D |
(4,011) |
52,675 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2015-06-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,042 |
56,686 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2016-06-06 |
5 |
OE |
$0.00 |
$0 |
D/D |
2,723 |
11,502 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2016-06-06 |
5 |
D |
$7.38 |
$5,026 |
D/D |
(681) |
10,821 |
0 |
- |
|
RLYP |
Relypsa Inc |
Director |
|
2016-06-07 |
4 |
S |
$19.31 |
$19,562 |
D/D |
(1,013) |
1,237 |
0 |
- |
|
RLYP |
Relypsa Inc |
Director |
|
2016-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
2,250 |
3,487 |
0 |
- |
|
RLYP |
Relypsa Inc |
Director |
|
2016-09-01 |
4 |
D |
$32.00 |
$39,584 |
D/D |
(1,237) |
2,250 |
0 |
- |
|
RLYP |
Relypsa Inc |
Director |
|
2016-09-01 |
4 |
D |
$32.00 |
$72,000 |
D/D |
(2,250) |
0 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2017-06-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,148 |
12,969 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2017-06-12 |
4 |
D |
$3.34 |
$1,794 |
D/D |
(537) |
12,432 |
0 |
- |
|
180 Records found
|
|
Page 1 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|